Percutaneous Closure of Left Atrial Appendage significantly affects Lipidome Metabolism

@inproceedings{Ycel2018PercutaneousCO,
  title={Percutaneous Closure of Left Atrial Appendage significantly affects Lipidome Metabolism},
  author={G{\"o}khan Y{\"u}cel and Michael Behnes and Carlo Barth and Annika Wenke and Benjamin Sartorius and Kambis Mashayekhi and B. Yazdani and Thomas Bertsch and Jonas Rusnak and AFM. Saleh and Ursula Hoffmann and Christian Fastner and Siegfried Lang and Xiaobo Zhou and Katherine J E Sattler and Martin Borggrefe and Ibrahim Akin},
  booktitle={Scientific Reports},
  year={2018}
}
Patients with non-valvular atrial fibrillation (AF) and a high risk for oral anticoagulation can be treated by percutaneous implantation of left atrial appendage occlusion devices (LAAC) to reduce the risk of cardio-embolic stroke. This study evaluates whether LAAC may influence lipid metabolism, which has never been investigated before. Patients with… CONTINUE READING